article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

It includes aspects such as home health visits, remote monitoring and diagnostics, direct-to-patient shipment of study drugs, and electronic informed consent. Additional details are provided with respect to the validity of certificates and “sell-off” periods.

article thumbnail

SQA Regulatory Surveillance Summary 3 | Monthly Update 2021

SQA

Establishing a Program for the Union’s Action in the Field of Health (EU4Health Programme) for the Period of 2021-2027, Regulation (EU) 2021/522, 24 March 2021. Regulation (EU) 2021/522 establishes a new and reinforced program for the Union’s action in the field of health, called the EU4Health Programme , for the period of 2021-2027.